CS-12192

N/A

Report date: 2023/05/18 20:00:22
NME

Base Information

Drug NameCS-12192
Drug Alias NameCS12192
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitorsSerine/threonine-protein kinase TBK1 inhibitorsTyrosine-protein kinase JAK1 inhibitors
TargetsSerine/threonine-protein kinase TBK1Tyrosine-protein kinase JAK3Tyrosine-protein kinase JAK1
Therapy Area/IndicationsGraft vs Host DiseaseAutoimmune DiseasesAlopecia Areata +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen Chipscreen Biosciences Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Chipscreen Pharmaceutical Co LtdShenzhen Chipscreen Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseAutoimmune DiseasesAlopecia Areata +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A